BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27592472)

  • 21. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization.
    Pei XQ; Liu LZ; Zheng W; Cai MY; Han F; He JH; Li AH; Chen MS
    Eur J Radiol; 2012 Mar; 81(3):e182-8. PubMed ID: 21349669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
    Sharma A; Grover SB; Mani C; Ahluwalia C
    Br J Radiol; 2021 May; 94(1121):20201160. PubMed ID: 33860674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.
    Zheng W; Xiong YH; Han J; Guo ZX; Li YH; Li AH; Pei XQ
    Br J Radiol; 2016 Sep; 89(1065):20150887. PubMed ID: 27340932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-quadrant fast compressive tracking of breast ultrasound videos for computer-aided response evaluation of neoadjuvant chemotherapy in mice.
    Yan Y; Tang L; Huang H; Yu Q; Xu H; Chen Y; Chen M; Zhang Q
    Comput Methods Programs Biomed; 2022 Apr; 217():106698. PubMed ID: 35217304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.
    Luengo-Gil G; González-Billalabeitia E; Chaves-Benito A; García Martínez E; García Garre E; Vicente V; Ayala de la Peña F
    Breast Cancer Res Treat; 2015 Jun; 151(3):577-87. PubMed ID: 25967462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancer.
    Lang SA; Moser C; Gehmert S; Pfister K; Hackl C; Schnitzbauer AA; Stroszczynski C; Schlitt HJ; Geissler EK; Jung EM
    Clin Hemorheol Microcirc; 2014; 56(4):287-99. PubMed ID: 23271198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy of breast cancer.
    Garces CA; Cance WG
    Am Surg; 2004 Jul; 70(7):565-9. PubMed ID: 15279176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Allevi G; Bolsi G; Aguggini S; Brunelli A; Betri E; Generali D; Scaratti L; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2002 Jun; 8(6):1816-21. PubMed ID: 12060622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of thyroid cancer in Chinese females with breast cancer by vascular endothelial growth factor (VEGF), microvessel density, and contrast-enhanced ultrasound (CEUS).
    Wei X; Li Y; Zhang S; Ming G
    Tumour Biol; 2014 Jul; 35(7):6521-9. PubMed ID: 24687553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regions of interest and parameters for the quantitative analysis of contrast-enhanced ultrasound to evaluate the anti-angiogenic effects of bevacizumab.
    Zhang HP; Shi QS; Li F; Liu L; Bai M; Gu JY; Wu Y; Du LF
    Mol Med Rep; 2013 Jul; 8(1):154-60. PubMed ID: 23722237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does color Doppler ultrasound vascularity predict the response to neoadjuvant chemotherapy in breast cancer?
    Boonjunwetwat D; Prueksadee J; Sampatanukul P; Chatamra K
    J Med Assoc Thai; 2005 Oct; 88(10):1367-72. PubMed ID: 16519381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer.
    Rix A; Piepenbrock M; Flege B; von Stillfried S; Koczera P; Opacic T; Simons N; Boor P; Thoröe-Boveleth S; Deckers R; May JN; Lammers T; Schmitz G; Stickeler E; Kiessling F
    Theranostics; 2021; 11(19):9557-9570. PubMed ID: 34646386
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
    Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
    NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer.
    Hatt M; Groheux D; Martineau A; Espié M; Hindié E; Giacchetti S; de Roquancourt A; Visvikis D; Cheze-Le Rest C
    J Nucl Med; 2013 Mar; 54(3):341-9. PubMed ID: 23327900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood flow indices by Doppler ultrasonography vary with neoadjuvant chemotherapy but are not related to plasma VEGF levels in locally advanced breast cancer.
    Oksuzoğlu B; Vural M; Abali H; Yilmaz M; Yildirim N; Zengin N
    Oncology; 2006; 71(3-4):185-9. PubMed ID: 17641536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of contrast-enhanced ultrasound in the pathological grading and prognosis prediction of hepatocellular carcinoma.
    Xuan Z; Wu N; Li C; Liu Y
    Transl Cancer Res; 2021 Sep; 10(9):4106-4115. PubMed ID: 35116708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer.
    Gschwantler-Kaulich D; Fink-Retter A; Hudelist G; Bachrich T; Ledesma M; Ruecklinger E; Kubista E; Singer CF
    J Chemother; 2007 Dec; 19(6):731-8. PubMed ID: 18230558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.